Replay available

MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call

MaxCyte, Inc. (NASDAQ: MXCT) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

Wed, November 12, 2025 at 4:30 PMendedReplay
MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Eric Abdao

Investor Relations

Meher Masood

President and Chief Executive Officer

Doug Swirsky

Chief Financial Officer

Matt LaRue

Analyst, William Blair

Matt Hewitt

Analyst, Craig Hallam Capital Group

Hannah Rayford

Analyst, Stevens Inc.

Brendan Smith

Analyst, TD Cowen

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the MAC site third quarter earnings conference call. At this time all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 11 on your telephone. You will then hear an automated message advising you your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Eric Abdao, Investor Relations. Please go ahead, sir. Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MacSite, we have Meher Masood, President and Chief Executive Officer, and Doug Swirsky, Chief Financial Officer. Earlier today, MacSite released financial results for the third quarter and it's September 30th, 2025. A copy of the press release is available on the company's website. Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within the meanings of federal securities laws. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in any forward-looking statements due to a variety of factors, which are discussed in detail in our SEC filings. Except as required by applicable law, The company has no obligation to publicly update any forward-looking statements, whether because of new information, future events, or otherwise. And with that, I will turn the call over to Mehar. Thank y...

More from Maxcyte, Inc.